DeepMed Research

Ethicon, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1992-01-01

Employees: 10K

Market Cap: -

Website: http://www.ethicon.com

Clinical Trials

The Fibrin Pad Cardiovascular Study

Phase 2

Completed

Conditions: Cardiovascular Disease

Interventions: Biological: Topical hemostat
Biological: EVARREST™
Other: Standard of Care

First Posted Date: 2012-09-07

Last Posted Date: 2018-06-12

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 42

Registration Number: NCT01681030

Locations: 🇺🇸
Clinical Investigation Site #1, Paterson, New Jersey, United States
🇺🇸
Clinical Investigation Site #3, New York, New York, United States
🇺🇸
Clinical Investigation Site #5, Indianapolis, Indiana, United States

and more 3 locations

The EVICEL® Gastrointestinal Study

Phase 2

Completed

Conditions: Gastrointestinal Diseases

Interventions: Biological: EVICEL Fibrin Sealant

First Posted Date: 2012-05-02

Last Posted Date: 2015-02-25

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 214

Registration Number: NCT01589822

Locations: 🇺🇸
Clinical Investigation Site #1, Irvine, California, United States
🇺🇸
Clinical Investigation Site #5, Augusta, Georgia, United States
🇺🇸
Clinical Investigation Site #2, Jacksonville, Florida, United States

and more 19 locations

A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

Phase 2

Completed

Conditions: Dura Defects

Interventions: Biological: Evicel
Other: Sutures only

First Posted Date: 2010-08-04

Last Posted Date: 2012-06-20

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 139

Registration Number: NCT01174992

Locations: 🇳🇱
VU Medical Centre, Amsterdam, Netherlands
🇧🇪
Department of Neurosurgery, Ziekenhuis Oost Limburg, Genk, Belgium
🇧🇪
Department of Neurosurgery, University Hospital of Liège, Liège, Belgium

and more 9 locations

The Fibrin Pad Liver Study

Phase 3

Completed

Conditions: Hemorrhage

Interventions: Biological: Fibrin Pad
Procedure: Standard of Care

First Posted Date: 2010-07-21

Last Posted Date: 2014-01-20

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 84

Registration Number: NCT01166243

Locations: 🇬🇧
Addenbrookes Hospital, Cambridge, United Kingdom
🇩🇪
University Hospital of the University of Saarland, Strasse, Germany
🇳🇿
Auckland City Hospital, Grafton, New Zealand

and more 5 locations

Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair

Completed

Conditions: Incisional Hernia
Ventral Hernia

Interventions: Device: NG-TSM

First Posted Date: 2010-07-14

Last Posted Date: 2011-04-27

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 48

Registration Number: NCT01162564

Locations: 🇺🇸
Eastern Virginia Medical School, Norfolk, Virginia, United States
🇺🇸
Washington University School of Medicine / Dept of Surgery, St. Louis, Missouri, United States
🇺🇸
Capital Region Hospital, Jefferson City, Missouri, United States

and more 3 locations

The Evicel Post-Authorization Surveillance Study

Completed

Conditions: Peripheral Vascular Disease
Hemorrhage

Interventions: Biological: EVICEL ™ Fibrin Sealant (Human)

First Posted Date: 2010-07-08

Last Posted Date: 2015-08-19

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 300

Registration Number: NCT01158261

Locations: 🇺🇸
Memorial Hospital, Jacksonville, Florida, United States
🇺🇸
Baptist Health Medical Center, Jacksonville, Florida, United States

A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device

Not Applicable

Terminated

Conditions: Uterine Fibroids

Interventions: Device: GYNECARE GYNOCCLUDE™

First Posted Date: 2010-06-09

Last Posted Date: 2011-02-17

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 2

Registration Number: NCT01140555

Locations: 🇩🇪
Frauenklinik, Universitatsklinikum Erlangen, Erlangen, Germany
🇳🇴
Ullevaal University Hospital, Department of Obstetrics & Gynaecology, Oslo, Norway
🇳🇱
Vrije Universiteit medisch centrum (VU Medical Center), Dept of Obstetrics and Gynaecology, Amsterdam, Netherlands

and more 1 locations

A Pilot Study to Evaluate the Clinical Effectiveness and Safety of the VFIX Device as Treatment for Apical Prolapse

Not Applicable

Completed

Conditions: Pelvic Organ Prolapse

Interventions: Device: VFIX Device

First Posted Date: 2010-04-27

Last Posted Date: 2014-10-13

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 20

Registration Number: NCT01111409

Locations: 🇦🇺
QEII Hospital, Brisbane, Australia
🇦🇺
Frances Perry House, Parkville, Australia
🇦🇺
Urogynaecology Unit, Royal Women's Hospital, Parkville, Australia

A Prospective Study of the NUVANCE Facial Rejuvenation System for Mid-Face, Neck and Jowl Rejuvenation Procedures

Not Applicable

Terminated

Conditions: Ptosis of the Neck, Mid-face and/or Jowl

Interventions: Device: NUVANCE Facial Rejuvenation System

First Posted Date: 2010-04-08

Last Posted Date: 2017-08-11

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 100

Registration Number: NCT01100190

Locations: 🇫🇷
Bernard Mole, Paris, France
🇩🇪
Martin-Luther-Krankenhaus, Berlin, Germany
🇫🇷
Catherine Bergeret-Galley, Paris, France

and more 6 locations

The Severe Soft Tissue Bleeding Study

Phase 3

Completed

Conditions: Soft Tissue Bleeding

Interventions: Biological: Fibrin Pad
Procedure: Standard of Care

First Posted Date: 2009-09-16

Last Posted Date: 2015-10-01

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 91

Registration Number: NCT00977925

Locations: 🇦🇺
Flinders Medical Centre, Bedford Park, Australia
🇦🇺
Bankstown Hospital, Bankstown, Australia
🇦🇺
The Townsville Hospital, Douglas, Australia

and more 13 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy